An overview of the success and failure of surgical therapy: Standards against which the outcome of endoscopic therapy is measured

Gastrointestinal Endoscopy Clinics of North America

Volumn 13, Issue 1, 2003, Pages 69-73

  Vakil, Nimish ^a   Canga III, Christino ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; PROTON PUMP INHIBITOR;

ENDOSCOPIC SURGERY; GASTROINTESTINAL REFLUX; HUMAN; LAPAROSCOPIC SURGERY; MAINTENANCE THERAPY; MEASUREMENT; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; REVIEW; STANDARD; STOMACH FUNDOPLICATION;

EID: 0037240724     PISSN: 10525157     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-5157(02)00111-3     Document Type: Review

References (15)

1. Rattner D, Brooks D. Patient satisfaction following laparoscopic and open antireflux surgery. Arch Surg 1995;130:289-94.
2. Hinder R, Perdikis G, Klingler P, DeVault K. The surgical option for gastroesophageal reflux disease. Am J Med 1997;103:144S-8S.
3. Eubanks T, Omelanczuk P, Richards C, Pohl D, Pellegrini C. Outcomes of laparoscopic antireflux procedures. Am J Surg 2000;179:391-5.
4. Lundell L, Miettinen P. Myrvold HE, et al. Continued (5-year) follow-up of a randomized clinical study comparing antireflux surgery and omeprazole in gastroesophageal reflux disease. J Am Coil Surg 2001;192:172-9.
5. Ye W, Chow W, Lagergren J, Yin L, Nyren O. Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastro-esophageal reflux diseases and after anti-reflux surgery. Gastroenterology 2001;121:1286-93.
6. van den Boom G, Go P, Hameeteman W, Dallemagne B, Ament A. Cost-effectiveness of medical versus surgical treatment in patients with severe or refractory gastroesophageal reflux disease in the Netherlands. Scand J Gastroenterol 1996;31:1-9.
7. Huedebert G, Marks R, Wilcox C, et al. Choice of long term strategy for the management of patients with severe esophagitis. A cost-utility analysis. Gastroenterology 1997;112:1078-86.
8. Viljakka M, Nevalainen J, Isolauri J. Lifetime costs of surgical versus medical treatment of severe gastroesophageal reflux disease in Finland. Scand J Gastroenterol 1997;32:766-72.
9. Lafullarde T, Watson D, Jameison G, Myers J, Game P, Devitt P. Laparoscopic Nissen fundoplication. Five-year results and beyond. Arch Surg 2001;136:180-4.
10. Luostarinen M, Virtanen J, Koskinen M, Matikainen M, Isolauri J. Dysphagia and oesophageal clearance after laparoscopic versus open Nissen fundoplication. A randomized prospective trial. Scand J Gastroenterol 2001;36:565-71.
11. Bammer T, Hinder R, Klaus A, Klinger P. Five-to-eight year outcome of the first laparoscopic Nissen fundoplications. J Gastrointest Surg 2001;5:42-8.
12. Rantanen T, Halme T, Luostarinen M, Karhumaki L, Kononen E, Isolauri J. The long term results of open antireflux surgery in a community-based health care center. Am J Gastroenterol 1999;94:1777-81.
13. Franzen T, Bostrom J, Tibbling G, Johansson K. Prospective study of symptoms and gastroesophageal reflux 10 years after posterior partial fundoplication. Br J Surg 1999;86:956-60.
14. Watson D, Baigrie R, Jameison G. A learning curve for laparoscopic fundoplication. Definable, avoidable, or a waste of time. Ann Surg 1996;224:198-203.
15. Klinkenberg-Knol EC, Nelis F, Dent J, et al. Walan A and the Long-term study group. Long-term omeprazole treatment in resistant gastro-esophageal reflux disease: efficacy, safety and influence on gastric mucosa. Gastroenterology 2000;118:661-9.